Product Images Safyral
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 14 images provide visual information about the product associated with Safyral NDC 50419-403 by Bayer Healthcare Pharmaceuticals Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
This is a chart displaying the levels of plasma folate (in nmol/L) over time, with values ranging from 0 to 100. The chart compares 196 individuals who took a medication called YAZ+levomefolate calcium to 66 individuals who took only YAZ. Data was collected at various time points over the course of 22 weeks.*
This text is discussing different methods of birth control, including the number of pregnancies per 100 women for each method. It lists various options such as injections, intrauterine devices, sterilization, birth control pills, condoms, diaphragms, and natural methods like abstaining during fertile days or withdrawal.*
This text provides a table showing the ranges of the number of women with blood clots per 10,000 women years for different conditions, including non-pregnant, non-COC user, COC user, pregnancy, and postpartum. The pregnancy data is based on actual duration of pregnancy in reference studies and the assumption that pregnancy lasts for nine months, with a rate of 7 to 27 per 10,000 WY.*
This appears to be a list of different studies and their corresponding hazard ratio, rate ratio, or odds ratio. The studies mentioned include Ingenix, EURAS, LASS, a FDA-funded study, a Danish study, a Danish re-analysis, MEGA, a German case-control study, and GPRD. There is also mention of different types of studies including prospective and retrospective cohort studies, case-control studies, and non-fatal idiopathic cases. It is difficult to provide a more specific description as the text seems to be missing important information and context.*
This text appears to be a table showing ranges of values for non-pregnant women, non-COC users, COC users, pregnancy, and postpartum. It also includes information on the number of women with a blood clot out of 10,000 women years, with a note indicating that the pregnancy data is based on actual duration of pregnancy in the reference studies, and that the rate is 7 o 27 per 10,000 WY assuming a pregnancy duration of nine months.*
This text appears to be a list of relevant studies on the risk of breast cancer associated with combined oral contraceptives. Each study is identified by its name, the year it was conducted, and the lead author. The text also includes some numbers, possibly representing risk estimates or statistical confidence intervals, but without further context, it is not clear what they mean.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.